Found: 14
Select item for more details and to access through your institution.
Genetics and molecular biology of chronic lymphocytic leukemia.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Negative selection of chronic lymphocytic leukaemia cells using a bifunctional rosette-based antibody cocktail.
- Published in:
- BMC Biotechnology, 2008, v. 8, p. 1, doi. 10.1186/1472-6750-8-6
- By:
- Publication type:
- Article
OSW-1: a Natural Compound With Potent Anticancer Activity and a Novel Mechanism of Action.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2005, v. 97, n. 23, p. 1781, doi. 10.1093/jnci/dji404
- By:
- Publication type:
- Article
New strategies to direct therapeutic targeting of PML to treat cancers.
- Published in:
- Frontiers in Oncology, 2013, v. 3, p. 1, doi. 10.3389/fonc.2013.00124
- By:
- Publication type:
- Article
Stem cell transplantation after alemtuzumab in T-cell prolymphocytic leukaemia results in longer survival than after alemtuzumab alone: a multicentre retrospective study.
- Published in:
- 2010
- By:
- Publication type:
- Letter
Mantle cell lymphoma with central nervous system involvement: frequency and clinical features.
- Published in:
- British Journal of Haematology, 2009, v. 147, n. 1, p. 83, doi. 10.1111/j.1365-2141.2009.07835.x
- By:
- Publication type:
- Article
Fludarabine combinations for patients with advanced marginal zone lymphomas – best treatment option or too toxic?
- Published in:
- 2009
- By:
- Publication type:
- Letter
All is not lost - the improving outcome of patients with chronic lymphocytic leukaemia failing frontline therapy with fludarabine, cyclophosphamide and rituximab.
- Published in:
- European Journal of Haematology, 2013, v. 91, n. 2, p. 189, doi. 10.1111/ejh.12138
- By:
- Publication type:
- Article
Cytogenetic response is not a prerequisite for clinical response in patients with myelodysplastic syndromes treated with azacitidine.
- Published in:
- European Journal of Haematology, 2011, v. 87, n. 2, p. 186, doi. 10.1111/j.1600-0609.2011.01653.x
- By:
- Publication type:
- Article
Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors.
- Published in:
- British Journal of Haematology, 2017, v. 177, n. 2, p. 324, doi. 10.1111/bjh.14062
- By:
- Publication type:
- Article
Phase 1 study of the safety, pharmacokinetics, and antitumour activity of the BCL2 inhibitor navitoclax in combination with rituximab in patients with relapsed or refractory CD20<sup>+</sup> lymphoid malignancies.
- Published in:
- British Journal of Haematology, 2015, v. 170, n. 5, p. 669, doi. 10.1111/bjh.13487
- By:
- Publication type:
- Article
Emergence of central nervous system myeloma in the era of novel agents.
- Published in:
- Hematological Oncology, 2012, v. 30, n. 4, p. 170, doi. 10.1002/hon.1021
- By:
- Publication type:
- Article
Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy.
- Published in:
- Annals of Hematology, 2014, v. 93, n. 7, p. 1193, doi. 10.1007/s00277-014-2040-1
- By:
- Publication type:
- Article
Fludarabine, cyclophosphamide, and rituximab for the treatment of patients with chronic lymphocytic leukemia or indolent non‐hodgkin lymphoma.
- Published in:
- Cancer (0008543X), 2006, v. 106, n. 11, p. 2412
- By:
- Publication type:
- Article